These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18937992)

  • 1. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuric and non-albuminuric pathways to renal impairment in diabetes.
    Macisaac RJ; Jerums G
    Minerva Endocrinol; 2005 Sep; 30(3):161-77. PubMed ID: 16208306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic kidney disease with and without albuminuria.
    Macisaac RJ; Jerums G
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):246-57. PubMed ID: 21422923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.
    Rosolowsky ET; Niewczas MA; Ficociello LH; Perkins BA; Warram JH; Krolewski AS
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S46-53. PubMed ID: 18849087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group.
    Rigalleau V; Lasseur C; Raffaitin C; Beauvieux MC; Barthe N; Chauveau P; Combe C; Gin H
    Diabetes Care; 2007 Aug; 30(8):2034-9. PubMed ID: 17485574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating albuminuria and GFR in the assessment of diabetic nephropathy.
    Jerums G; Panagiotopoulos S; Premaratne E; MacIsaac RJ
    Nat Rev Nephrol; 2009 Jul; 5(7):397-406. PubMed ID: 19556994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
    Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
    Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
    Molitch ME
    Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
    Cherney DZ; Sochett EB; Dekker MG; Perkins BA
    Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is proteinuria such an important risk factor for progression in clinical trials?
    Jerums G; Panagiotopoulos S; Tsalamandris C; Allen TJ; Gilbert RE; Comper WD
    Kidney Int Suppl; 1997 Dec; 63():S87-92. PubMed ID: 9407431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
    Hovind P; Tarnow L; Rossing P; Teerlink T; Stehouwer CD; Emeis JJ; Parving HH
    Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation.
    Coresh J; Auguste P
    Scand J Clin Lab Invest Suppl; 2008; 241():30-8. PubMed ID: 18569962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type 2 diabetic nephropathy: clinical course and prevention proposals 2004].
    Tarchini R; Bottini E; Botti P; Marseglia CD; Talassi E; Baraldi O; Lambertini D; Gaetti L; Bellomi A
    G Ital Nefrol; 2005; 22 Suppl 31():S15-9. PubMed ID: 15786392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention.
    Bachorzewska-Gajewska H; Malyszko J; Malyszko JS; Musial W; Dobrzycki S
    Nephrology (Carlton); 2006 Dec; 11(6):549-54. PubMed ID: 17199796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.